A Multi-Institutional Study of Magnetic Resonance/Ultrasound Fusion–Guided Nanoparticle-Directed Focal Therapy for Prostate Ablation
Nanoparticle-directed focal laser ablation of neoplastic prostate tissue resulted in 73% of patients with successful treatment at 12 months post treatment, confirmed by negative MR/US fusion biopsy of the treated lesion and a systematic biopsy.
Authors
- Varaha S. Tammisetti (ORCID: https://orcid.org/0000-0002-2682-621X)
- Yara Kadria-Vili
- Arvin K. George (ORCID: https://orcid.org/0000-0002-6285-0655)
- Joshua S. Jue (ORCID: https://orcid.org/0000-0002-8624-9784)
- Ardeshir R. Rastinehad (ORCID: https://orcid.org/0000-0002-2074-5849)
- Matthew S. Davenport (ORCID: https://orcid.org/0000-0001-7943-7851)
- Steven E. Canfield (ORCID: https://orcid.org/0000-0001-7898-3578)
- Naomi J. Halas (ORCID: https://orcid.org/0000-0002-8461-8494)
- Mahir Maruf (ORCID: https://orcid.org/0000-0002-1385-4270)
- Sara Lewis (ORCID: https://orcid.org/0000-0002-4713-6453)
- Jennifer West
- Jon A. Schwartz
- Leonardo D. Borregalaes
Institutions
- Northwell Health (US)
- Michigan Medicine (US)
- Arthur Smith Institute for Urology (US)
- Nanospectra Biosciences (United States) (US)
- University of Virginia (US)
- Rice University (US)
- The University of Texas Health Science Center at Houston (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- The Journal of Urology
- Published
- 2024-09-03
- DOI
- https://doi.org/10.1097/ju.0000000000004222
- Citations
- 12
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 5.03
Funders
- Pfizer